Dr. Alexander Chehrazi-Raffle discusses findings from the phase 3 TiNivo-2 trial, designed to evaluate treatment with Fotivda in patients with metastatic renal cell carcinoma.
Dr. Alexander Chehrazi-Raffle
Advertisement
Articles by Dr. Alexander Chehrazi-Raffle
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
New Strategy May Prevent Breast Cancer Relapse
2
FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care
3
Understanding the Evolving Role of a Pathologist in Lung Cancer Care
4
All FDA Oncology Approvals From September 2025
5
